Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/34583
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSu, Elizabeth-
dc.contributor.authorLiew, David Fl-
dc.contributor.authorDonnelly, Jane-
dc.contributor.authorElliott, Rohan A-
dc.date.accessioned2023-12-18T00:04:48Z-
dc.date.available2023-12-18T00:04:48Z-
dc.date.issued2023-08-
dc.identifier.citationAustralian Prescriber 2023-08; 46(2)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/34583-
dc.description.abstractMedicines stewardship refers to coordinated strategies and interventions to optimise medicines use, usually within a specific therapeutic area. Medicines stewardship programs can reduce variations in practice and improve patient outcomes. Therapeutic domains for medicines stewardship are chosen to address frequently used drug classes associated with a high risk of adverse outcomes. Some examples include antimicrobial, opioid analgesic, anticoagulation and psychotropic stewardship. Common elements of successful stewardship programs include multidisciplinary leadership, stakeholder engagement, tailored communication strategies, behavioural changes, implementation science methodologies, and ongoing program monitoring, evaluation and reporting. Medicines stewardship is a continual quality improvement process that requires ongoing support and resources, as well as clinician and consumer engagement, to remain sustainable. It is critical for hospital-based medicines stewardship programs to consider impacts on care in the community when making and communicating changes to patient therapy. This ensures that stewardship efforts are sustained across transitions of care.en_US
dc.language.isoeng-
dc.subjectanticoagulation stewardshipen_US
dc.subjectantimicrobial stewardshipen_US
dc.subjectmedicines stewardshipen_US
dc.subjectopioid analgesic stewardshipen_US
dc.subjectpsychotropic stewardshipen_US
dc.subjectquality use of medicinesen_US
dc.titleMedicines stewardship.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAustralian Prescriberen_US
dc.identifier.affiliationAustin Healthen_US
dc.identifier.affiliationDepartment of Medicine, University of Melbourne.;Council of Australian Therapeutic Advisory Groups.;Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne.en_US
dc.identifier.doi10.18773/austprescr.2023.010en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-9893-5546en_US
dc.identifier.orcid0000-0001-8451-8883en_US
dc.identifier.orcid0000-0002-7750-9724en_US
dc.identifier.pubmedid38053566-
dc.description.volume46-
dc.description.issue2-
dc.description.startpage24-
dc.description.endpage28-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptPharmacy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

60
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.